New immune defenders added to blood cell

August 7, 2018, Walter and Eliza Hall Institute of Medical Research
New immune defenders added to blood cell
New immune cells were discovered by a research team including (from left) Dr Kirsten Fairfax, Ms Kim De Menezes, Dr Carolyn de Graaf, Dr Jessica Bolden and Mr Merle Dayton. Credit: Walter and Eliza Hall Institute of Medical Research

Our researchers have revealed the identities of new subsets of immune cells at the frontline of our body's defenses against infection.

The research team's discovery expands the understanding of called granulocytes – immune cells that can trigger inflammation and engulf microbes to slow an infection's progress. As well as protecting against infection, granulocytes contribute to such as asthma and allergy.

The research, led by Walter and Eliza Hall Institute researchers Dr. Carolyn de Graaf, Dr. Kirsten Fairfax and Dr. Jessica Bolden, extends to the team's extensive 'atlas' of blood cells, called Haemopedia. The new findings were published in two articles in the Journal of Leukocyte Biology.

Distinguishing new cell types

Our immune system is a complex network of cells working together to prevent infection and keep us healthy. However, excessive or misdirected immune cell activity can drive inflammatory conditions such as asthma and allergies.

Granulocytes are critical 'front line' cells in our immune system, serving as a rapid defense against infection by engulfing invading microbes, triggering inflammation and alerting other immune cells to the threat.

The surface of granulocytes is covered with molecules that influence the cells' function, Dr. de Graaf said. "Our team focused our attention on a surface molecule called Siglec-F, which had previously been implicated in 'switching off' a type of granulocyte called eosinophils," she said.

Eosinophils are important triggers of inflammation in response to parasitic infections, but are also key players in inflammatory diseases such as asthma and allergies.

Credit: Walter and Eliza Hall Institute of Medical Research
"We discovered we could divide eosinophils into two 'populations' based on how much Siglec-F they had on their surface," Dr. de Graaf said. "These two populations appeared to differ in their maturity, and thus in their function within the body. This is the first time differences in gene expression in these two populations have been documented."

Mapping cells for a global resource

The research is part of a larger project to map the expression of the body's 20,000 genes in different types of . The database of this information, Haemopedia, is freely available as a resource for the global research community.

"By comparing the genes that each eosinophil population expressed, we identified differences that further distinguished the two populations," Dr. de Graaf said.

"By making this information available to other researchers through Haemopedia, we hope it can accelerate research into eosinophils. This may help to unravel diseases linked to eosinophils such as asthma and allergies, as well as cancers of eosinophils including eosinophilic leukaemia and hypereosinophilic syndrome, a rare myeloproliferative neoplasm."

Unravelling immune cell development

The team also investigated the development of eosinophils and other related granulocytes. These cells develop in the bone marrow, originating from blood stem cells, said Dr. Fairfax.

"The developing granulocytes transition through immature stages known as before becoming different populations of mature granulocytes, such as ," she said.

"Using flow cytometry, we could follow the development of progenitors through different stages in the bone marrow. We discovered the amount of Siglec-F on the surface of cells varied as the cells developed. This allowed us to identify a never-before identified precursor marked by Siglec-F, which could also give rise to macrophages, another immune cell closely related to granulocytes," she said.

The discovery, which has also been documented in Haemopedia, adds extra detail to the understanding of how the many different types of immune cells develop from . "This discovery may also impact monitoring of patients in clinical trials targeting the Siglec family as a treatment for eosinophilic diseases," said Dr. Fairfax.

The expert technical support available at the Walter and Eliza Hall Institute was vital for the project's success. "These discoveries would not have been possible without the expertise of our bioservices staff, in particular Ms Keti Florides, Mr Merle Dayton and Ms Kim De Menezes," Dr. Fairfax said.

Explore further: Stress-fighting proteins could be key to new treatments for asthma

More information: Kirsten A. Fairfax et al. Transcriptional profiling of eosinophil subsets in interleukin-5 transgenic mice, Journal of Leukocyte Biology (2018). DOI: 10.1002/JLB.6MA1117-451R

Jessica E. Bolden et al. Identification of a Siglec-F+ granulocyte-macrophage progenitor, Journal of Leukocyte Biology (2018). DOI: 10.1002/JLB.1MA1217-475R

Related Stories

Stress-fighting proteins could be key to new treatments for asthma

July 6, 2015
Investigators have discovered the precise molecular steps that enable immune cells implicated in certain forms of asthma and allergy to develop and survive in the body. The findings from Weill Cornell Medical College reveal ...

Some blood stem cells are better than others

May 30, 2018
In your body, blood stem cells produce approximately 10 billion new white blood cells, which are also known as immune cells, each and every day. Even more remarkably, if some of these blood stem cells fail to do their part, ...

MyD88—villain of allergies and asthma

January 30, 2018
Even if you don't have allergies yourself, I guarantee you can list at least three people you know who have allergies. Asthma, a respiratory disorder commonly associated with allergies, afflicts over 300 million individuals ...

Muscle repair after injury helped by fat-forming cells

April 19, 2013
(Medical Xpress)—UC San Francisco scientists have discovered that muscle repair requires the action of two types of cells better known for causing inflammation and forming fat.

New role for immune cells in preventing diabetes and hypertension

March 17, 2017
Immune cells which are reduced in number by obesity could be a new target to treat diseases such as type 2 diabetes and hypertension that affect overweight people, according to a collaborative study between The University ...

Recommended for you

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

New immunotherapy targeting blood-clotting protein

October 15, 2018
Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier—which keeps large molecules in the blood from entering the brain—becomes abnormally permeable, ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Immune health maintained by meticulously ordered DNA

October 15, 2018
Walter and Eliza Hall Institute researchers have revealed how immune health is maintained by the exquisite organisation skills of a protein called Pax5.

Enzyme that triggers autoimmune responses from T-cells in patients with MS found

October 11, 2018
A team of researchers from Switzerland, the U.S. and Spain has isolated an enzyme that triggers an autoimmune response from T-cells in patients with MS. In their paper published in the journal Science Translational Medicine, ...

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.